The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUAI.L Regulatory News (UAI)

  • There is currently no data for UAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal of Share in Harwell Campus

2 Apr 2020 07:00

RNS Number : 5004I
U and I Group PLC
02 April 2020
 

2 April 2020

 

U and I Group PLC

 

 

U+I disposes of its share in the Harwell Campus, delivering development and trading gains of approximately £11 million

 

U+I (LSE:UAI), the specialist regeneration developer and investor, today announces that it has exchanged on the sale of its holding in Harwell Campus, the world leading science and technology campus in Oxfordshire, to Brookfield Capital Partners ("Brookfield"), on behalf of Brookfield Strategic Real Estate Partners III ("BSREP III"), for an initial cash payment of £28 million, plus deferred payments of £13.74 million. This delivers development and trading gains to U+I of approximately £11 million, subject to formal audit. The Company expects these gains to be in FY2020, subject to discussions with its auditors. U+I has also sold its 100% owned, adjoining Gemini Building to Brookfield for £7.5 million, marginally above book value, giving an aggregate net cash receipt of c.£44 million.

 

The disposal of U+I's share of the joint venture in Harwell follows an extensive marketing and due diligence process which saw strong interest from a number of international investors, attracted by the potential of this internationally renowned 700-acre science campus, grounded in over £2 billion of world-leading scientific infrastructure. The additional sale of the Gemini Building, held in our investment portfolio, was opportunistic and reflected a fair value for this asset, whilst providing additional cash to our business.

 

U+I will provide an unaudited post close trading update on 15 April.

 

Matthew Weiner, CEO of U+I said:

"Brookfield has a trusted reputation for nurturing and growing assets in the real estate sector. We felt they were the right choice to drive the next stage of growth at this internationally renowned innovation and science campus in the Oxford corridor, giving Harwell the capital commitment it needs to unlock its potential for the future as a hub for pioneering research. With such strong demand for science and research led facilities, it was the right time for U+I to sell its share in the joint venture, which also provides a significant cash injection that further strengthens U+I's balance sheet."

 

 

ENDS

 

 

For further information, please contact: 

 

U+I

Nicola Krafft

+44 (0) 20 7828 4777

ir@uandiplc.com

 

Camarco (Financial PR Adviser)

Geoffrey Pelham-Lane / Tom Huddart

+44 (0)20 3757 4985 / 4991

uandi@camarco.co.uk 

 

About U+I

U+I is a specialist regeneration developer and investor.

 

With a >£11.5 billion portfolio of complex, mixed-use, community-focused regeneration projects including a £147.1 million investment portfolio, we are unlocking urban sites bristling with potential in the London City Region (within one hour's commute from Central London), Manchester and Dublin. We exist to create long-term socio-economic benefit for the communities in which we work, delivering sustainable returns to our shareholders.

 

To find out more, visit www.uandiplc.com or follow us @uandiplc  

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISUPUPUCUPUPUG
Date   Source Headline
10th Mar 20162:50 pmRNSAppointment of Non-Executive Director
9th Mar 201612:20 pmRNSHolding(s) in Company
18th Feb 201610:20 amRNSHolding(s) in Company
16th Feb 201611:08 amRNSHolding(s) in Company
16th Feb 201610:36 amRNSHolding(s) in Company
15th Feb 20164:10 pmRNSHolding(s) in Company
15th Feb 20167:00 amRNSGBP2.3m profit realised from Charlemont sale
12th Feb 201611:22 amRNSHolding(s) in Company
20th Jan 20164:54 pmRNSHolding(s) in Company
12th Jan 20164:55 pmRNSDirector/PDMR Shareholding
11th Jan 201611:23 amRNSDirector/PDMR Shareholding
7th Jan 20162:57 pmRNSDirector/PDMR Shareholding
31st Dec 20157:00 amRNSTotal Voting Rights
22nd Dec 201511:13 amRNSHolding(s) in Company
22nd Dec 201510:37 amRNSDirector/PDMR Shareholding
16th Dec 20157:00 amRNSDisposal in Waterloo generates further profit
15th Dec 201510:31 amRNSBlocklisting Interim Review
9th Dec 20157:00 amRNSPeter Williams appointed as Chairman Designate
7th Dec 20157:00 amRNSProfit realised from Braehead and Watford sales
3rd Dec 20155:04 pmRNSDirector/PDMR Shareholding
3rd Dec 20152:20 pmRNSHolding(s) in Company
3rd Dec 20157:00 amRNSPlanning, funding and pre-sale at Ilford project
1st Dec 201510:41 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSProfit realised from sale in Abbey Wood
18th Nov 20153:23 pmRNSDirector/PDMR Shareholding
18th Nov 20153:22 pmRNSDirector/PDMR Shareholding
18th Nov 20153:19 pmRNSDirector/PDMR Shareholding
16th Nov 201511:32 amRNSDirector/PDMR Shareholding
5th Nov 20155:15 pmRNSChange of Name
3rd Nov 201510:10 amRNSDirector/PDMR Shareholding
22nd Oct 20152:01 pmRNSDirector/PDMR Shareholding
22nd Oct 20151:13 pmRNSDirector/PDMR Shareholding
22nd Oct 20151:12 pmRNSDirector/PDMR Shareholding
21st Oct 20157:00 amRNSInterim Results to 31 August 2015
20th Oct 20155:16 pmRNSProposed Change of Company Name
9th Oct 201511:21 amRNSBlocklisting Interim Review
1st Oct 20158:39 amRNSHolding(s) in Company
16th Sep 20152:46 pmRNSNotice of Interim Results
14th Aug 201512:17 pmRNSDirector/PDMR Shareholding
28th Jul 20159:57 amRNSHolding(s) in Company
22nd Jul 20157:00 amRNSAcquisition of EUR6.0m development site in Dublin
15th Jul 20157:00 amRNSFunding secured for Dublin office building
14th Jul 20153:02 pmRNSResult of AGM
1st Jul 20152:27 pmRNSDirector/PDMR Shareholding
17th Jun 201511:34 amRNSBlocklisting Interim Review
16th Jun 20153:24 pmRNSDirector/PDMR Shareholding
9th Jun 20157:00 amRNSAcquisition of two investment assets in Dublin
8th Jun 20154:53 pmRNSDirector/PDMR Shareholding
22nd May 20154:02 pmRNSAnnual Financial Report
22nd May 201512:29 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.